Benign prostatic hyperplasia, which can be abbreviated as prostatic hyperplasia, is a urinary system disease that has a high incidence in middle-aged and elderly male populations in China. The incidence of benign prostatic hyperplasia is increasing year by year. Patients with benign prostatic hyperplasia are prone to have bladder outlet obstruction, which in turn leads to an increase in residual urine volume in the bladder and impurities in the urine, such as upper urinary calculi that enter the bladder, urine crystals, various exfoliated cells, etc. If these substances stay in the bladder for a long time, stones in the bladder will be generated. Benign prostatic hyperplasia with bladder stones can severely obstruct the urinary tract, causing clinical symptoms such as urinary tract infections, urinary urgency, frequent urination, and dysuria. These symptoms seriously affects the physical and mental health of patients, leading to low levels of normal work and quality of life. With the development of medical technology, surgical treatment is commonly used in clinical practice. Among them, transurethral prostatectomy is widely used in clinical treatment, and has achieved good results.
Research Progress of Transurethral Prostatectomy for Benign Prostatic Hyperplasia with Bladder Stones